NewsNation17h
FDA approves at-home chlamydia, gonorrhea, trichomoniasis test for women
Visby Medical Women’s Sexual Health Test can be taken by those with or without symptoms,and delivers results in about 30 ...
Stockhead on MSN1d
Scott Power: ASX health stocks fall but… Orthocell nails its US FDA approval
In the midst of tariff mayhem this week, finally some good news has landed, with Orthocell gaining a big FDA ... Read More ...
Amgen gets expanded FDA label approval for Uplizna
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
FDA Approves Second Indication for Amgen's Immune System Treatment Uplizna
Amgen said the Food and Drug Administration approved Uplizna for Immunoglobulin G4-related disease, the second approved indication. The biotechnology company said Thursday the FDA granted breakthrough ...
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...
FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Pharmaceutical Technology2d
FDA grants accelerated approval to Novartis’ Vanrafia for IgAN
The FDA has granted accelerated approval to Novartis’ Vanrafia for adults with primary immunoglobulin A nephropathy (IgAN).
Withings $150 blood pressure monitor is FDA approved and out now
Withings . Withings has announced its BPM Vision blood pressure monitor will be available in the U.S. from April 2, having cleared the Food and Drug Administration (FDA)’s strin ...
US FDA insider Steele replaces Marks as top vaccine official, for now
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
LogicMark secures approval to deliver new medical alter with cell phone tech
LogicMark (LGMK) announced a major breakthrough in senior care access. The company’s Freedom Alert Max, its latest medical alert innovation, ...
MIRA Pharmaceuticals Enrolls First Subjects in Phase 1 Clinical Trial of Ketamir-2 for Neuropathic Pain
MIAMI, FLORIDA / ACCESS Newswire / April 1, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and ...